Bachem
Compare Bachem…Swiss pure-play peptide CDMO; largest globally. CHF ~400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
SectorsGLP-1
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
BachemSwiss pure-play peptide CDMO; largest globally. CHF ~400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
Basic shares represent total shares issued. Diluted shares include potential shares from stock options, convertible securities, and other equity awards.
H1 2016 — H2 2025